Why the study?
What is the diagnostic value of fluid cytology and the survival outcome in lung cancer patients with symptomatic pericardial effusion?
What is the diagnostic value of fluid cytology and the survival outcome in lung cancer patients with symptomatic pericardial effusion?
Pericardial effusion in lung cancer indicates rapid tumor progression and short survival, with fluid cytology providing an accurate diagnostic tool.
Answers are grounded in this paper and cite their sources.
Cytology may aid diagnosis in lung cancer pericardial effusion; leaves open prognostic implications from this small case series.
During the years 1975-1988, twenty lung cancer patients with symptomatic pericardial effusion were treated conservatively at our center. Echocardiography demonstrated small pericardial effusion in 2 patients, medium size effusion in 3 patients and large amount of fluid in 15 patients. Fifteen patients developed cardiac tamponade; in three of these patients, this was the presenting manifestation of lung cancer. Pericardiocentesis resulted in prompt, though temporary, symptomatic relief in all patients. Fluid cytology demonstrated suspected malignant cells in 2 patients and malignant cells in 13 patients. Based on cytology, the diagnosis of adenocarcinoma was established in six patients, small cell carcinoma in three patients, and epidermoid carcinoma in one patient. All patients were dead within 9 months from the time of diagnosis of pericardial effusion; 17 died within less than 3 months. It is concluded that pericardial effusion in lung cancer is indicative of rapid tumor progression and short survival. Fluid cytology provides an immediate and accurate means of diagnosis.
No takes yet. Share an insight, caveat, or question.
Edoute et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: